Feng Liu

Abstract CT074: Tumor mutational burden (TMB) as a biomarker of survival in metastatic non-small cell lung cancer (mNSCLC): Blood and tissue TMB analysis from MYSTIC, a Phase III study of first-line durvalumab ± tremelimumab vs chemotherapy.

Solange Peters, Byoung Chul Cho, Niels Reinmuth et al. · Cancer Research · 2019 · 76 citations

Medicine, Oncology, Pharmacology +17

Influencing factors of pregnancy loss and survival probability of clinical pregnancies conceived through assisted reproductive technology

Lingmin Hu, Jiangbo Du, Hong Lv et al. · Reproductive Biology and Endocrinology · 2018 · 57 citations · Full text

Medicine, Gynecology, Obstetrics +13

Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM).

Nizar J. Bahlis, Noopur Raje, Caitlin Costello et al. · Journal of Clinical Oncology · 2021 · 42 citations

Medicine, Hematology, Pharmacology +17

Type 2 diabetes prevention diet and the risk of pancreatic cancer: A large prospective multicenter study

Yan Huang, Feng Liu, Amei Chen et al. · Clinical Nutrition · 2021 · 31 citations · Full text

Medicine, Nutrition, Nutritional Sciences +16

Intraluminal implantation of radioactive stents for treatment of primary carcinomas of the peripancreatic-head region: a pilot study

Yan Liu, Zheng Lu, Duowu Zou et al. · Gastrointestinal Endoscopy · 2009 · 29 citations

Medicine, Nuclear Medicine, Surgery +8